Intracranial Antitumor Responses of Nivolumab and Ipilimumab: A Pharmacodynamic and Pharmacokinetic Perspective, a Scoping Systematic Review

BMC Cancer - United Kingdom
doi 10.1186/s12885-019-5741-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Nivolumab Plus Ipilimumab Achieves Responses in dMMR/MSI-H Tumors

Cancer Discovery
Oncology
2018English

Evaluation of Pharmacokinetic, Pharmacodynamic, Efficacy, and Safety Data of Low-Dose Ticagrelor Versus Standard Dose in East Asians: A Systematic Review

Therapeutics and Clinical Risk Management
2018English

A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim

AAPS Journal
Pharmaceutical Science
2018English

Roles for Librarians in Systematic Reviews: A Scoping Review

Journal of the Medical Library Association : JMLA
MedicineInformation SciencesLibraryHealth Informatics
2018English

Paraneoplastic Hyperleucocytosis in a Melanoma Patient After Initiation of Ipilimumab and Nivolumab Combination Therapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2018English

Criteria for Enhancing Mucus Transport: A Systematic Scoping Review

Multidisciplinary Respiratory Medicine
PulmonaryRespiratory Medicine
2018English

Erratum to a Review of Its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Use in the Treatment of Arrhythmias

Drugs
Pharmacology
1991English

A Pharmacokinetic and Pharmacodynamic Comparison of Plain and Enteric- Coated Prednisolone Tablets.

British Journal of Clinical Pharmacology
Pharmacology
1992English

Severe Hemophagocytic Lymphohistiocytosis in a Melanoma Patient Treated With Ipilimumab + Nivolumab

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy